CD30-directed Immunoconjugate class drugs

FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

1 result

Adcetris (brentuximab vedotin)

(brentuximab vedotin)

Manufacturer:SEAGEN INC.

Usage: ADCETRIS is indicated for treating previously untreated or relapsed Classical Hodgkin Lymphoma (cHL), Systemic Anaplastic Large Cell Lymphoma (sALCL), and relapsed or refractory Large B-Cell Lymphoma (LBCL) in adults, often in combination with chemotherapy. It is also approved for pediatric high-risk cHL.